drugset / Trial / NCT06407947
Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
This trial is a single-arm, single-center, open-label clinical trial to evaluate the safety, efficacy, and metabolism kinetics of CT071 in patients with high-risk newly diagnosed multiple myeloma.
Timeline
- Start
- 2024-06-06
- Primary completion
- 2027-06-03
- Completion
- 2027-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CT071 | Cell therapy | — | — |